True Wealth Design’s Day One Biopharmaceuticals DAWN Stock Holding History

True Wealth Design’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-128	Closed	-$2.75K	–	2712
2026 Q1	$2.75K	Buy	128 +102	+392%	+$1.44K	﹤0.01%	1417
2025 Q4	$243	Buy	+26	New	+$217	﹤0.01%	2179
2025 Q3	–	Sell	-54	Closed	-$351	–	2761
2025 Q2	$351	Sell	54 -26	-33%	-$179	﹤0.01%	1871
2025 Q1	$635	Buy	+80	New	+$862	﹤0.01%	1453
2024 Q4	–	Sell	-4	Closed	-$56	–	1404
2024 Q3	$56	Buy	+4	New	+$57	﹤0.01%	1251

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's DAWN Position: Q2 2026 in Review

True Wealth Design sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 128 shares — an estimated $2.75K sold.

True Wealth Design first reported a position in DAWN in Q3 2024 and held it in 5 quarters. The position peaked at $2.75K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

True Wealth Design reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
True Wealth Design sold 128 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.75K.
True Wealth Design first reported a position in Day One Biopharmaceuticals in Q3 2024 and held it in 5 quarters.
True Wealth Design's Day One Biopharmaceuticals position peaked at $2.75K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.